Vimarsana
Biggest News Aggregation in the World

Page 25 - Ancer Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ancer Prostate Today - Breaking & Trending Today

$38,398 for a Single Shot of a Very Old Cancer Drug - Vimarsana News

$38,398 for a Single Shot of a Very Old Cancer Drug

Why are US hospitals -- which may pay as little as $260 for the drug -- charging so much more to administer it?

Move to Shorter Hypofractionated RT for High-Risk Prostate Cancer - Vimarsana News

Move to Shorter Hypofractionated RT for High-Risk Prostate Cancer

A shorter course of hypofractionated radiotherapy should be considered for patients with high-risk prostate cancer, say trialists, who report that efficacy and toxicity are similar to longer standard regimens.

How Early Can Imaging Assess Response in End-Stage Prostate Cancer? - Vimarsana News

How Early Can Imaging Assess Response in End-Stage Prostate Cancer?

177Lu-PSMA SPECT at cycle three (week 12) of six cycles of PSMA-targeted treatment predicted progression-free survival for men with end-stage metastatic castration-resistant prostate cancer.

High PSMA Predicts Targeted Therapy Response in Prostate Cancer - Vimarsana News

High PSMA Predicts Targeted Therapy Response in Prostate Cancer

High PSMA (mean SUV of 10 or greater) predicts good response to 177Lu-PSMA-617 and promises to help clinicians optimize the best patients to treat with the radioligand therapy, researchers say.

Inside Excess Deaths From Cancer and COVID Early in the Pandemic - Vimarsana News

Inside Excess Deaths From Cancer and COVID Early in the Pandemic

Although the findings focus on deaths before vaccines became available, the data can help researchers better understand some of the burden COVID-19 had on patients with cancer.